FANCD2 and cervical carcinoma: We have extended our previously published work28 to generate a common fragile-site dataset in cervical carcinoma cell lines using higher resolution mapping of FANCD2 binding and have mapped cellular enhancers and super-enhancers in an HPV16-positive cell line derived from a cervical lesion29 using H3K27ac and Brd4 chromatin immunoprecipitation sequencing (ChIP-seq) (Fig. 1).